Company Overview of PhaseRx, Inc.
PhaseRx, Inc. is developing RNA nanomedicines for the treatment of orphan liver disease. Its SMARTT Polymer Technology provides the ability to deliver messenger RNA therapeutics to selected tissues in vivo, thereby unlocking the value of mRNA as a therapeutic modality. The company was incorporated in 2006 and is based in Seattle, Washington.
410 West Harrison Street
Seattle, WA 98119
Founded in 2006
Key Executives for PhaseRx, Inc.
PhaseRx, Inc. Key Developments
Similar Private Companies By Industry
|Arrowhead Madison, Inc.||United States|
|4Tech, Inc.||United States|
|Viridax Corporation||United States|
|Berkeley Bioengineering Co.||United States|
|Cordis Neurovascular, Inc.||United States|
Recent Private Companies Transactions
December 21, 2015
To contact PhaseRx, Inc., please visit www.phaserx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.